GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Price-to-Funds-From-Operations

Toleranzia AB (OSTO:TOL) Price-to-Funds-From-Operations : (As of May. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Toleranzia AB (OSTO:TOL) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.